Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen

  1. Fleeman, N.
  2. Payne, K.
  3. Newman, W.G.
  4. Howell, S.J.
  5. Boland, A.
  6. Oyee, J.
  7. Saborido, C.M.
  8. Santander, A.F.
  9. Dickson, R.
Revue:
Personalized Medicine

ISSN: 1741-0541 1744-828X

Année de publication: 2013

Volumen: 10

Número: 6

Pages: 601-611

Type: Article

DOI: 10.2217/PME.13.60 GOOGLE SCHOLAR